Your browser doesn't support javascript.
loading
Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease.
Giannakou, Konstantinos; Golenia, Aleksandra; Liabeuf, Sophie; Malyszko, Jolanta; Mattace-Raso, Francesco; Farinha, Ana; Spasovski, Goce; Hafez, Gaye; Wiecek, Andrzej; Capolongo, Giovanna; Capasso, Giovambattista; Massy, Ziad A; Pépin, Marion.
Afiliação
  • Giannakou K; Department of Health Sciences, School of Sciences, European University Cyprus, Nicosia, Cyprus.
  • Golenia A; Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
  • Liabeuf S; Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens University Medical Center, Amiens, France.
  • Malyszko J; MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France.
  • Mattace-Raso F; Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Farinha A; Department of Geriatric Medicine, Erasmus MC University Medical Center, Rotterdam, Netherlands.
  • Spasovski G; Department of Nephrology, Hospital de Vila Franca de Xira, Vila Franca de Xira, Portugal.
  • Hafez G; University Department of Nephrology, Clinical Centre "Mother Theresa"University Sts Cyril and Methodius, Skopje, North Macedonia.
  • Wiecek A; Department of Pharmacology, Faculty of Pharmacy, Altinbas University, Istanbul, Türkiye.
  • Capolongo G; Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia in Katowice, Katowice, Poland.
  • Capasso G; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Massy ZA; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Pépin M; Biogem Research Institute, Ariano Irpino, Italy.
Front Med (Lausanne) ; 10: 1215583, 2023.
Article em En | MEDLINE | ID: mdl-37621458
Chronic kidney disease (CKD) affects approximately 850 million people globally and is associated with an increased risk of cognitive impairment. The prevalence of cognitive impairment among CKD patients ranges from 30 to 60%, and the link between CKD and cognitive impairment is partially understood. Methodological challenges and biases in studying cognitive function in CKD patients need to be addressed to improve diagnosis, treatment, and management of cognitive impairment in this population. Here, we review the methodological challenges and study design issues, including observational studies' limitations, internal validity, and different types of bias that can impact the validity of research findings. Understanding the unique challenges and biases associated with studying cognitive function in CKD patients can help to identify potential sources of error and improve the quality of future research, leading to more accurate diagnoses and better treatment plans for CKD patients.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article